Cure Forward Corp. — Form D/A

Cure Forward Corp. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2017-05-18. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Other Technology.

Offering

Filed: 2017-05-18
Form: D/A
Accession: 0001624526-17-000001
Industry: Other Technology
Exemptions: 06b
Total offering: $4.5M
Amount sold: $4.5M
Investors: 1
Date of first sale: 2016-12-16
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-276663

Issuer

Name: Cure Forward Corp.
CIK: 0001624526
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2012
Address: 263 SUMMER STREET, BOSTON, MA, 02210
Phone: 650-463-4052

Officers, directors & promoters (10)

Name	Role	Location
Seth Harrison	Director	Redwood City, CA
Frank Ingari	Director	Portland, OR
Aaron Kantoff	Director	Rockville, MD
Stephanie Papes	Director	Portland, OR
Steve Hau	Executive Officer	Boston, MA
Frank Ingari	Executive Officer	Portland, OR
Preston Brice	Director	Coral Gables, FL
Martin Naley	Director	Cambridge, MA
Martin Naley	Executive Officer	Cambridge, MA
Lauren Farrell	Executive Officer	Cambridge, MA

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2016-12-20	D	$4.0M	$4.0M
2016-09-29	D	$6.1M	$4.3M
2015-06-22	D	$15.0M	$3.5M
2015-06-22	D/A	$4.0M	$4.0M
2014-11-14	D	$2.0M	$500K

More